Antidiabetic activity of Commiphora mukul and Phyllanthus emblica and Computational analysis for the identification of active principles with dipeptidyl peptidase IV inhibitory activity (Record no. 15861)

MARC details
000 -LEADER
fixed length control field a
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20211231110228.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 211231b xxu||||| |||| 00| 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency AIKTC-KRRC
Transcribing agency AIKTC-KRRC
100 ## - MAIN ENTRY--PERSONAL NAME
9 (RLIN) 15278
Author Mohanty, Ipseeta Ray
245 ## - TITLE STATEMENT
Title Antidiabetic activity of Commiphora mukul and Phyllanthus emblica and Computational analysis for the identification of active principles with dipeptidyl peptidase IV inhibitory activity
250 ## - EDITION STATEMENT
Volume, Issue number Vol.53(5), Sep-Oct
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Mumbai
Name of publisher, distributor, etc. Wolter Kluwer
Year 2021
300 ## - PHYSICAL DESCRIPTION
Pagination 384-387p.
520 ## - SUMMARY, ETC.
Summary, etc. The medicinal plants may serve as natural alternatives to synthetic antidiabetic medications such<br/>as dipeptidyl peptidase‑IV (DPP‑IV) inhibitors, which are commonly prescribed in clinical practise.<br/>The medicinal plants: Commiphora mukul and Phyllanthus emblica have considerable DPP‑IV<br/>inhibitory efficacy, according to our findings. The present study is an extension of the previous<br/>study conducted in our laboratory and was designed to confirm the antidiabetic effects of C. mukul<br/>and P. emblica in the streptozotocin diabetes model and elucidate the active principles responsible<br/>for DPP‑IV inhibition. C. mukul (Guggul) and P. emblica (Amla) have the ability to inhibit DPP‑IV<br/>and have anti‑diabetic properties in a Type 2 diabetes mellitus experimental model. The binding<br/>sites and affinity of the active principles of C. mukul (Gluggusterone E, Gluggusterone Z) and<br/>P. emblica (Pzrogallol, beta‑glucogallin, and gallic acid) responsible for DPP‑IV enzyme inhibition<br/>were identified using in silico studies and compared to Vildagliptin, a synthetic DPP‑IV inhibitor. The<br/>Vildagliptin and therapy groups had significantly lower glycated hemoglobin and DPP‑IV levels. The<br/>anti‑diabetic effect of C. mukul and P. emblica is due to their DPP‑IV inhibitory action. The DPP‑IV<br/>inhibitory action of Gluggusterone E, Gluggusterone Z, and beta‑Glucogallin was found to be superior<br/>to Vildagliptin in docking tests.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
9 (RLIN) 4774
Topical term or geographic name entry element PHARMACOLOGY
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 15279
Co-Author Selvaa Kumar, C.
773 0# - HOST ITEM ENTRY
International Standard Serial Number 0253-7613
Place, publisher, and date of publication Andheri - Mumbai Wolters Kluwer India Private Limited
Title Indian Journal of Pharmacology
856 ## - ELECTRONIC LOCATION AND ACCESS
URL https://www.ijp-online.com/temp/IndianJPharmacol535384-1955428_052554.pdf
Link text Click here
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Articles Abstract Database
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Shelving location Date acquired Total Checkouts Barcode Date last seen Price effective from Koha item type
    Dewey Decimal Classification     School of Pharmacy School of Pharmacy Archieval Section 31/12/2021   2021-2022678 31/12/2021 31/12/2021 Articles Abstract Database
Unique Visitors hit counter Total Page Views free counter
Implemented and Maintained by AIKTC-KRRC (Central Library).
For any Suggestions/Query Contact to library or Email: librarian@aiktc.ac.in | Ph:+91 22 27481247
Website/OPAC best viewed in Mozilla Browser in 1366X768 Resolution.